Alpha 1 Biomedicals, SciClone sales and marketing update

Frank Vander Werf, SCLN's president and COO, said the company's planned March 17 launch in Singapore of Thymosin alpha I will be delayed indefinitely.

SCLN said heavy trading in its shares last week primarily was due to speculation over the delay. ...